BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 14729977)

  • 1. ASPP1 and ASPP2: common activators of p53 family members.
    Bergamaschi D; Samuels Y; Jin B; Duraisingham S; Crook T; Lu X
    Mol Cell Biol; 2004 Feb; 24(3):1341-50. PubMed ID: 14729977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax.
    Patel S; George R; Autore F; Fraternali F; Ladbury JE; Nikolova PV
    Nucleic Acids Res; 2008 Sep; 36(16):5139-51. PubMed ID: 18676979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
    Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
    Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
    Robinson RA; Lu X; Jones EY; Siebold C
    Structure; 2008 Feb; 16(2):259-68. PubMed ID: 18275817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
    Bergamaschi D; Samuels Y; Zhong S; Lu X
    Oncogene; 2005 May; 24(23):3836-41. PubMed ID: 15782125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
    Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
    Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of functions within the p53/p63/p73 family.
    De Laurenzi V; Melino G
    Ann N Y Acad Sci; 2000; 926():90-100. PubMed ID: 11193045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73.
    Dietz S; Rother K; Bamberger C; Schmale H; Mössner J; Engeland K
    FEBS Lett; 2002 Aug; 525(1-3):93-9. PubMed ID: 12163168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 family: at the crossroads in cancer therapy.
    Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
    Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
    Dohn M; Zhang S; Chen X
    Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional repressor hDaxx potentiates p53-dependent apoptosis.
    Gostissa M; Morelli M; Mantovani F; Guida E; Piazza S; Collavin L; Brancolini C; Schneider C; Del Sal G
    J Biol Chem; 2004 Nov; 279(46):48013-23. PubMed ID: 15339933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASPP1 and ASPP2 are new transcriptional targets of E2F.
    Fogal V; Kartasheva NN; Trigiante G; Llanos S; Yap D; Vousden KH; Lu X
    Cell Death Differ; 2005 Apr; 12(4):369-76. PubMed ID: 15731768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p53/p63/p73 family of transcription factors: overlapping and distinct functions.
    Levrero M; De Laurenzi V; Costanzo A; Gong J; Wang JY; Melino G
    J Cell Sci; 2000 May; 113 ( Pt 10)():1661-70. PubMed ID: 10769197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53 family: same response, different signals?
    Chen X
    Mol Med Today; 1999 Sep; 5(9):387-92. PubMed ID: 10462750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers].
    Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for ASPP2 recognition by the tumor suppressor p73.
    Canning P; von Delft F; Bullock AN
    J Mol Biol; 2012 Nov; 423(4):515-27. PubMed ID: 22917970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.